Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
Davis Polk advised the sales agent in connection with a new SEC-registered at-the-market offering by Inventiva S.A. of its American depositary shares (ADSs) under which Inventiva may sell up to an aggregate amount of $58 million of ADSs. Inventiva’s ADSs are listed on the Nasdaq Global Market under the symbol “IVA,” and its ordinary shares are listed on Euronext Paris under the same symbol.
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with unmet medical need.
The Davis Polk capital markets team included partners Deanna L. Kirkpatrick and Yasin Keshvargar and associate Sean Choi. Partner David R. Bauer and associate S. Dream Montgomery provided intellectual property advice. All members of the Davis Polk team are based in the New York office.